Latest gabapentin Stories

2009-04-30 11:31:22

A drug widely used to treat seizures and anxiety appears to be an effective treatment for restless legs syndrome (RLS) and helps people with the disorder get a better night's sleep, according to a study that will be presented as part of the Late-breaking Science Program at the American Academy of Neurology's 61st Annual Meeting in Seattle, April 25 – May 2, 2009. RLS affects up to one in ten people.

2009-03-31 22:46:50

The painkiller oxycodone is effective in dulling the acute discomfort of shingles, an illness that often causes agony in sufferers, U.S.

2009-01-09 07:30:00

LONDON, RESEARCH TRIANGLE PARK, N.C. and SANTA CLARA, Calif., Jan. 9 /PRNewswire-FirstCall/ -- GlaxoSmithKline and XenoPort, Inc. announced today that GSK has resubmitted the New Drug Application (NDA) to the U.S.

2008-12-17 08:35:00

The drugs that cure epileptic seizures are known to increase the risk of suicide, and federal regulators decided Tuesday drug companies must clearly display that warning.

2008-12-16 14:56:47

The U.S.

2008-11-07 15:00:21

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a March 31, 2008 decision by the District Court, which had found TAP Pharmaceutical Products Inc.'s U.S. Patent No. 4,628,098 valid and enforceable.

2008-11-03 15:00:21

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) today announced results of a study in which Azilect(R) (rasagiline tablets) demonstrated selective MAO-B inhibition at the approved dose of 1mg. Non selective MAO inhibitors may have some contra indications with certain foods and drugs.

2008-10-27 06:00:23

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has entered into a settlement agreement with an institution that acted as a broker in placing investments in Teva's portfolio of auction rate securities.

2008-10-20 06:00:22

Depomed, Inc. (NASDAQ:DEPO) announced today the enrollment and dosing of the first patient in Breeze 2, the second of two pivotal Phase 3 clinical trials in Depomed's registration program for DM-5689 (formerly referred to as Gabapentin GR(R)) for the treatment of menopausal hot flashes.

2008-10-16 06:00:31

Depomed, Inc. (NASDAQ:DEPO) today announced that it will release third quarter financial results for 2008 after the market closes on Thursday, October 30, 2008. The company will webcast a conference call beginning at 5:00 p.m. ET, 2:00 p.m.

Word of the Day
  • A poem in which the author retracts something said in an earlier poem.
The word 'palinode' comes from Greek roots meaning 'again' and 'song'.